ALLOPLEX BIOTHERAPEUTICS

alloplex-biotherapeutics-logo

Alloplex Biotherapeutics operates as a privately-owned Boston-based cellular therapeutics company. It has developed a non-engineered, tumor-agnostic cellular therapy platform with broad anti-tumor activity.

#SimilarOrganizations #People #Financial #Website #More

ALLOPLEX BIOTHERAPEUTICS

Social Links:

Industry:
Biopharma Biotechnology Health Care Therapeutics

Founded:
2016-01-01

Address:
Boston, Massachusetts, United States

Country:
United States

Website Url:
http://www.alloplexbio.com

Total Employee:
1+

Status:
Active

Total Funding:
21.2 M USD

Technology used in webpage:
Euro Cloudflare Hosting


Similar Organizations

chimeron-bio-logo

Chimeron Bio

Chimeron Bio develops agents for personalized cancer gene therapy.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

scout-bio-logo

Scout Bio

Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.

tmunity-therapeutics-logo

Tmunity Therapeutics

Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells

verismo-therapeutics-logo

Verismo Therapeutics

Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.

Current Employees Featured

frank-borriello_image

Frank Borriello
Frank Borriello Founder and CEO @ Alloplex Biotherapeutics
Founder and CEO
2016-01-01

Founder


frank-borriello_image

Frank Borriello

Investors List

hanall-biopharma_image

HanAll Biopharma

HanAll Biopharma investment in Corporate Round - Alloplex Biotherapeutics

daewoong-pharmaceutical_image

Daewoong Pharmaceutical

Daewoong Pharmaceutical investment in Corporate Round - Alloplex Biotherapeutics

Official Site Inspections

http://www.alloplexbio.com

  • Host name: 141.193.213.10
  • IP address: 141.193.213.10
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Alloplex Biotherapeutics"

About Alloplex - Alloplex Biotherapeutics

Alloplex is led by its scientific founder and CEO, Dr. Frank Borriello MD, PhD โ€“ a Harvard-trained immunologist with over two decades pharmaceutical industry experience where he held positions of increasing responsibility, beginning as โ€ฆSee details»

Alloplex Biotherapeutics - Crunchbase Company Profile โ€ฆ

Alloplex Biotherapeutics operates as a privately-owned Boston-based cellular therapeutics company. It has developed a non-engineered, tumor-agnostic โ€ฆSee details»

Cancer therapy Investment opportunities - Alloplex Biotherapeutics

See details»

Alloplex Biotherapeutics Inc - Org Chart, Teams, Culture & Jobs

View Alloplex Biotherapeutics Inc's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

Alloplex Biotherapeutics - Overview, News & Similar ... - ZoomInfo

Alloplex Biotherapeutics Inc is a privately owned Boston-based cellular therapeutics company with headquarters and laboratories located in Woburn M A, USA; and a wholly owned subsidiary โ€ฆSee details»

Alloplex Biotherapeutics Company Profile | Management and

Alloplex Biotherapeutics Profile and History. Alloplex Biotherapeutics Inc is a privately owned Boston-based cellular therapeutics company with headquarters and laboratories located in โ€ฆSee details»

Frank Borriello - advancedtherapiesweek.phacilitate.com

Dec 1, 2021 Since then โ€“ as Scientific Founder and CEO of Alloplex โ€“ Dr. Borriello has led the organization through research, fundraising and business development, to Phase 1 clinical trials for SUPLEXA therapy which โ€ฆSee details»

Alloplex Biotherapeutics Inc - LinkedIn

Alloplex Biotherapeutics is dedicated to exploring the higher order combinatorial space of immunomodulators to develop an effective anti-tumor vaccine. This approach is applicable to all tumor ...See details»

Alloplex Biotherapeutics, Inc - VentureRadar

Website: https://www.alloplexbio.com/ Develops a unique, non-engineered cellular therapy platform with extensive anti-tumor capabilities, applicable across various ...See details»

Alloplex Biotherapeutics, LLC - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Alloplex Biotherapeutics, LLC of Winchester, MA. Get the latest business insights from Dun & Bradstreet.See details»

A novel tumor-agnostic cellular therapy platform

Scientific summary. Since 2016, Alloplex has engaged in extensive research to refine and develop the original concept conceived by Frank Borriello, MD, PhD (U.S. Patent 10,731,128).Alloplex โ€ฆSee details»

Alloplex Biotherapeutics - Craft

Alloplex Biotherapeutics is a company that specializes in the development of cellular therapies. It provides SUPLEXA cells, a peripheral blood mononuclear cell (PBMC)-derived multicellular โ€ฆSee details»

The CDI Experts: Renowned Scientist Korngold, at Retirement โ€ฆ

Dec 15, 2021 Led by Scientific Founder and CEO, Dr. Frank Borriello, M.D., Ph.D, the organization has developed an autologous cellular therapy derived from peripheral blood โ€ฆSee details»

Alloplex Biotherapeutics, Inc. (Alloplex Biotherapeutics, Inc.) - ่ฏ็‰ฉ โ€ฆ

2546 Background: SUPLEXA therapeutic cells are the initial autologous and non-engineered candidate to emerge from the novel ENLIST cells training platform. Manufacturing is robust, โ€ฆSee details»

Alloplex set to validate crucial immunotherapy hypothesis and โ€ฆ

Mar 27, 2024 Email: [email protected] Attn: Lesley White, Alloplex Australia. For media requests on deadline during USA Eastern hours, please call: +1-781-281-2013. For Investors. โ€ฆSee details»

Frank Borriello - Phacilitate

Since then โ€“ as Scientific Founder and CEO of Alloplex โ€“ Dr. Borriello has led the organization through research, fundraising and business development, to Phase 1 clinical trials for โ€ฆSee details»

Media and Press - Alloplex Biotherapeutics

Email: [email protected] Attn: Lesley White, Alloplex Australia. For media requests on deadline during USA Eastern hours, please call: +1-781-281-2013. For Investors. Executive โ€ฆSee details»

Alloplexโ€™s Suplexa reawakens immune cells to fight cancer

Nov 26, 2024 When it comes to cell therapy, Alloplex Biotherapeutics Inc. CEO Frank Borriello said he believes that autologous, personalized therapy is the only thing that makes sense. โ€ฆSee details»

Alloplex to present emerging data from SUPLEXA-101 trial at โ€ฆ

Apr 19, 2023 Media Contact. To request interviews, high res images or other materials, media are asked to: Email: [email protected] Attn: Lesley White, Alloplex Australia. For media โ€ฆSee details»

linkstock.net © 2022. All rights reserved